wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38704952-6B9D0B8B-1E31-4C26-A948-9D61A00F59A8
Q38704952-6B9D0B8B-1E31-4C26-A948-9D61A00F59A8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38704952-6B9D0B8B-1E31-4C26-A948-9D61A00F59A8
The selective c-Met inhibitor tepotinib can overcome epidermal growth factor receptor inhibitor resistance mediated by aberrant c-Met activation in NSCLC models.
P2860
Q38704952-6B9D0B8B-1E31-4C26-A948-9D61A00F59A8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38704952-6B9D0B8B-1E31-4C26-A948-9D61A00F59A8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1437d94481c4510fe98a7581c3c86c7d890c14b5
P2860
Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer.